Serotonin receptor (5-HTR2A) and dysbindin (DTNBP1) genes and component process variables of short-term verbal memory in schizophrenia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 109, Issue 7, 2009, Pages 70-75

  Alfimova, M V ^a   Monakhov, M V ^a   Abramova, L I ^a   Golubev, S A ^a   Golimbet, V E ^a  

^a NONE

Author keywords

Dysbindin; Gene polymorphism; Genetics of schizophrenia; Proactive interference; Serotonin; Short term verbal memory

Indexed keywords

EID: 70349121703     PISSN: 19977298     EISSN: 19977298     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Russian Source.
2. Russian Source.
3. Russian Source.
4. Russian Source.
5. Russian Source.
6. Abdolmaleky H.M., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 2004; 67: 53-62.
7. Aleman A., Hijman R., de Haan E.H.F., Kahn R. Memory Impairment in Schizophrenia: A Meta-Analysis. Am J Psychiat 1999; 156: 1358-1366.
8. Brockhaus-Dumke A., Mueller R., Faigle U., Klosterkoetter J. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophr Res 2008; 99: 238-249.
9. Burdick K.E., Lencz T., Funke B. et al. Genetic Variation in DTNBP1 Influences General Cognitive Ability. Hum Mol Genet 2006; 15: 1563-1568.
10. Burdick K.E., Goldberg T.E., Funke B. et al. DTNBP1 Genotype Influences Cognitive Decline in Schizophrenia. Schizophr Res 2007; 89: 169-172.
11. Chen R.Y., Sham P., Chen E.Y. et al. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiat Res 2001; 105: 175-185.
12. Cirillo M.A., Seidman L.J. Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev 2003; 13: 43-77.
13. de Quervain D.J.F., Henke K., Aerni A. et al. A functional genetic variation of 5-HT2a receptor affects human memory. Nat Neurosci 2003; 6: 1141-1142.
14. Donders J. A confirmatory factor analysis of the California Verbal Learning Test-Second Edition (CVLT-II) in the standardization sample. Assessment 2008; 15: 123-131.
15. Donohoe G., Morris D.W., Clarke S. et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 2007; 45: 454-458. (Pubitemid 44828767)
16. Funke B., Finn C.T., Plocik A.M. et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004; 75: 891-898.
17. Golimbet V.E., Alfimova M.V., Kaleda V.G. et al. Verbal memory deficit in schizophrenia as a possible endophenotype of the disease. Schizoaffective Disorders: New Research. Ed. Murray W.H. NY: Nova Science Publishers 2006; 165-186.
18. Golimbet V.E., Lavrushina O.M., Kaleda V.G. et al. Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: a large-scale case-control and family-based study. Eur Psychiat 2007; 22: 167-170.
19. González-Burgos I., Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog Brain Res 2008; 172: 603-623.
20. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiat 1996; 153: 321-330.
21. Kouzmenko A.P., Scaffidi A., Pereira A.M. et al. Schizophrenia and the serotonin-2A receptor promoter polymorphism. Hum Hered 1999; 49: 103-105.
22. Parsons M.J., D'Souza U.M., Arranz M.J. et al. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiat 2004; 56: 406-410.
23. Peñas-Lledó E.M., Dorado P., Cáceres M.C. et al. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs. Clin Chem Lab Med 2007; 45: 835-838.
24. Ranganath Ch., Minzenberg M.J., Ragland J.D. The Cognitive Neuroscience of Memory Function and Dysfunction in Schizophrenia. Biol Psychiat 2008; 64: 18-25.
25. Reynolds C.A., Jansson M., Gatz M., Pedersen N.L. Longitudinal change in memory performance associated with HTR2A polymorphism. Neurobiol Aging 2006; 27: 150-154.
26. Roman F.S., Marchetti E. Involvement of 5-HT receptors in learning and memory. IDrugs 1998; 1: 109-121.
27. Serretti A., Drago A., De Ronchi D. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr Med Chem 2007; 14: 2053-2069.
28. Sigmund J.C., Vogler C., Huynh K.D., de Quervain D.J., Papassotiropoulos A. Fine-mapping at the HTR2A locus reveals multiple episodic memoryrelated variants. Biol Psychol 2008; 79: 239-242.
29. Spurlock G., Heils A., Holmans P. et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiat 1998; 3: 42-49.
30. Stefanis N.C., Trikalinos T.A., Avramopoulos D. et al. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiat 2007; 62: 784-792.
31. Tosato S., Ruggeri M., Bonetto C. et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiat Genet 2007; 144B: 647-659.
32. Toulopoulou T., Murray R.M. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother 2004; 4: 43-52.
33. Wagner M., Schuhmacher A., Schwab S. et al. The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans. Int J Neuropsychopharmacol 2008; 9: 1-5.
34. Warren J.T., Peacock M.L., Rodrigues L.C., Fink A.G. An Msp1 polymorphism in the human serotonin receptor gene (5HTR2A): Detection by DGGE and FLP analysis. Hum Mol Genet 1993; 2: 338.
35. Weickert C.S., Straub R.E., McClintock B.W. et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiat 2004; 61: 544-555.
36. Williams J., Spurlock G., McGuffin P. et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre association study of Schizophrenia (EMASS) Group. Lancet 1996; 347: 9011.
37. Whyte M.C., McIntosh A.M., Johnstone E.C., Lawrie S.M. Declarative memory in unaffected adult relatives of patients with schizophrenia: a systematic review and meta-analysis. Schizophr Res 2005; 78: 13-26.